###begin article-title 0
Kinetics of Wnt-Driven beta-Catenin Stabilization Revealed by Quantitative and Temporal Imaging
###end article-title 0
###begin p 1
Conceived and designed the experiments: RNH. Performed the experiments: RNH. Analyzed the data: RNH. Wrote the paper: RNH.
###end p 1
###begin p 2
The Wnt/beta-catenin signal transduction pathway regulates a broad range of developmental processes. Aberrant activation of the Wnt pathway leads to cancer and degenerative diseases. beta-catenin is a key signaling molecule that is frequently used as a direct monitor of Wnt pathway activation. This paper describes a multi-parametric method for quantitative analysis of cellular beta-catenin protein levels in a rapid and high-throughput manner. The assay offers temporally resolved detection of Wnt-stimulated accumulation of beta-catenin, simultaneously detecting cell number, and it sheds light onto the kinetics of posttranslational stabilization of beta-catenin.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 126 129 123 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003498-Fuerer1">[1]</xref>
###xml 131 134 128 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003498-Polakis1">[2]</xref>
###xml 136 139 133 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003498-Logan1">[3]</xref>
###xml 1275 1278 1251 1254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003498-Kim1">[4]</xref>
###xml 1280 1283 1256 1259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003498-Naik1">[5]</xref>
###xml 113 118 <span type="species:ncbi:9606">human</span>
The Wnt/beta-catenin canonical pathway plays key roles in development and in the progression of several types of human cancer [1], [2], [3]. beta-catenin is an important positive regulator of this signaling pathway, and is dephosphorylated and subsequently stabilized upon binding of Wnt ligands to the cell surface. A consequence of this increase in cytoplasmic beta-catenin levels is the concomitant translocation of beta-catenin to the nucleus where it interacts with transcriptional coactivators to initiate transcription of Wnt target genes. Since beta-catenin is critical for relaying the Wnt signal, researchers frequently quantify total cellular levels of beta-catenin to measure Wnt response or to detect perturbations of the pathway. The standard detection method relies on gel electrophoresis coupled with western blotting to quantify total endogenous protein. The limitations of this method are that it is low-throughput, requires large number of cells and contains inherent variability due to gel lane loading, thus hindering the rapid parallel analysis of multiple samples. Other methods for detecting beta-catenin stabilization rely on the expression of beta-catenin fused to genetically-encoded reporters such as green fluorescent protein (GFP) or luciferase [4], [5], but these may result in artifacts due to beta-catenin over expression. Cellular toxicity due to transfection is another frequently encountered problem.
###end p 4
###begin title 5
Results and Discussion
###end title 5
###begin p 6
###xml 234 237 231 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003498-Kishida1">[6]</xref>
###xml 728 737 710 719 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1A</bold>
###xml 728 737 710 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003498-g001"><bold>Figure 1A</bold></xref>
###xml 836 843 815 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s3">methods</xref>
###xml 921 924 900 903 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003498-Smith1">[7]</xref>
###xml 1083 1086 1059 1062 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003498-Yun1">[8]</xref>
###xml 1202 1211 1178 1187 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1B</bold>
###xml 1202 1211 1178 1187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003498-g001"><bold>Figure 1B</bold></xref>
###xml 1471 1483 1444 1456 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1B, C</bold>
###xml 1471 1483 1444 1456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003498-g001"><bold>Figure 1B, C</bold></xref>
###xml 1644 1645 1617 1618 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1745 1754 1718 1727 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1D</bold>
###xml 1745 1754 1718 1727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003498-g001"><bold>Figure 1D</bold></xref>
###xml 2092 2101 2065 2074 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1E</bold>
###xml 2092 2101 2065 2074 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003498-g001"><bold>Figure 1E</bold></xref>
###xml 148 153 <span type="species:ncbi:10090">mouse</span>
I developed a rapid, quantitative and high-throughput method for measuring Wnt-induced changes in endogenous beta-catenin levels. The assay employs mouse L-cells because they are an established model system for studying Wnt signaling [6]. beta-catenin in L-cells is predominantly distributed in the cytoplasm and is not present at cell junctions, allowing direct measurement of changes in Wnt-responsive cytoplasmic beta-catenin pools. After seeding in a 384-well plate at a density of 5000 cells/well for 24 h, cells were stimulated with purified Wnt3a ligand for 10 h at 37degreesC. The cells were then fixed and processed for staining with fluorophores in the infrared range to simultaneously detect beta-catenin and nuclei (Figure 1A). Anti-beta-catenin antibody concentration was optimized for best signal to background ratio (see methods), detected by secondary IR800 antibody (800 nm). DNA staining with DRAQ5 dye [7] (700 nm) was used as a marker to normalize beta-catenin signal for cell number, particularly important for monitoring a pathway known to affect proliferation [8]. Whole-cell fluorescent images of entire wells were acquired at low resolution at 700 nm (red) and 800 nm (green) (Figure 1B). L-cells stimulated with Wnt3a ligand exhibit 11-fold elevated levels of total beta-catenin compared to non-stimulated cells without changes in the total DNA content as shown by an increase in the green signal, making the merged signal more yellow than red (Figure 1B, C). The assay is highly reproducible with a standard deviation within 10% of the mean of replicates (n = 4). Moreover, there is an excellent linear correlation (R2 = 0.997) between the measured DNA fluorescence and the actual number of cells plated in each well (Figure 1D), thus allowing for sensitive monitoring of fluctuations in cell number under various treatment conditions. Because the assay is conducted in a 384-well plate format, it minimizes reagent usage and is readily scalable. For example, an entire dose response curve of Wnt3a in quadruplicate can be obtained in 6 h using one 384-well plate (Figure 1E). All of this is in sharp contrast to the standard method of preparing individual lysates for analyzing beta-catenin by western blotting.
###end p 6
###begin title 7
Description and validation of a quantitative method for temporal detection of cellular beta-catenin.
###end title 7
###begin p 8
###xml 38 43 <span type="species:ncbi:10090">mouse</span>
(A) Schematic of the assay. m denotes mouse species. (B) A representative output infrared image of L-cells treated with or without Wnt3a (100 ng/ml) for 10 h. The image shows whole-cell fluorescence from actual wells of a 384-well plate, highlighting increase in beta-catenin signal (green, 700 nm) without change in cellular DNA content (red, 800 nm, detected by DRAQ5). (C) Quantification of the beta-catenin signal from (B). The signal is background subtracted and normalized to DNA fluorescence. Values represent the mean+/-SEM from quadruplicate experiments. (D) Linearity of measured DNA fluorescence (DRAQ5 signal) versus actual number of L-cells plated per well. (E) Dose titration of Wnt3a at 24 h illustrating half-maximal activation of cellular beta-catenin in L-cells occurs at 33 ng/ml ligand.
###end p 8
###begin p 9
###xml 279 282 267 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003498-Polakis2">[9]</xref>
###xml 284 288 272 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003498-Rubinfeld1">[10]</xref>
###xml 347 351 332 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003498-Klein1">[11]</xref>
###xml 406 410 387 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003498-Lee1">[12]</xref>
###xml 483 492 461 470 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2A</bold>
###xml 483 492 461 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003498-g002"><bold>Figure 2A</bold></xref>
###xml 604 613 579 588 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2A</bold>
###xml 604 613 579 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003498-g002"><bold>Figure 2A</bold></xref>
###xml 799 803 764 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003498-Park1">[13]</xref>
###xml 860 869 822 831 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2B</bold>
###xml 860 869 822 831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003498-g002"><bold>Figure 2B</bold></xref>
###xml 961 965 919 923 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003498-Emami1">[14]</xref>
###xml 1073 1082 1025 1034 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure S1</bold>
###xml 1073 1082 1025 1034 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003498.s001"><bold>Figure S1</bold></xref>
To validate the sensitivity of the assay, intracellular beta-catenin levels were measured in response to various treatments known to modulate the Wnt/beta-catenin pathway. GSK3beta is a serine-threonine kinase involved in beta-catenin phosphorylation, leading to its degradation [9], [10]. L-cells treated with the GSK3beta inhibitor LiCl (50 mM) [11] or the proteasome/calpain inhibitor MG132 (25 microM) [12] showed a marked increase in beta-catenin fluorescence within 30-60 min (Figure 2A). L-cells treated with Wnt3a (100 ng/ml) showed a similar profile of time-dependent beta-catenin accumulation (Figure 2A). As expected, treatment with Wnt3a in the presence of quercetin (100 microM), a natural product that inhibits Wnt/beta-catenin signaling without altering cytosolic beta-catenin levels [13], had no effect on time-dependent beta-catenin response (Figure 2B). Similarly, treatment with Wnt3a in the presence of the Wnt inhibitor ICG-001 (10 microM) [14] that acts downstream of beta-catenin had no significant effects on beta-catenin stabilization as expected (Figure S1). These examples illustrate the power of our assay to temporally resolve intracellular levels of beta-catenin under various conditions, and to readily detect the fast response of beta-catenin to GSK3beta or proteasome inhibitors at relatively short treatment times. In summary, this new method is versatile and can be readily adapted to a high-throughput format. It can also be utilized for assessing the cellular effects of inhibitors of GSK3beta on beta-catenin accumulation, or for screening compounds for Wnt pathway inhibition.
###end p 9
###begin title 10
Monitoring cellular beta-catenin accumulation in response to various stimuli.
###end title 10
###begin p 11
###xml 165 172 161 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s3">methods</xref>
(A) L-cells were treated with either Wnt3a (50 ng/ml), LiCl (50 mM) or MG132 (25 microM) for the indicated periods of time and processed for imaging as described in methods. (B) Monitoring the effects of a pharmacologic inhibitor of Wnt signaling on beta-catenin accumulation. L-cells were treated with Wnt3a (50 ng/ml) in the absence or presence of 100 microM quercetin for the indicated times. Each point represents mean+/-SEM (n = 3-4).
###end p 11
###begin p 12
###xml 491 499 482 490 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3</bold>
###xml 491 499 482 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003498-g003"><bold>Figure 3</bold></xref>
To determine if the increase in beta-catenin fluorescence upon Wnt3a addition reflects posttranslational stabilization of beta-catenin or new protein synthesis, L-cells were treated with either cycloheximide, a protein synthesis inhibitor, or actinomycin D, a DNA transcription inhibitor. Over 6 h, Wnt3a-dependent accumulation of beta-catenin shows an almost indistinguishable profile in the absence or presence of actinomycin D, but is severely impacted upon treatment with cycloheximide (Figure 3). This shows that protein translation is absolutely required for Wnt-mediated accumulation of beta-catenin; it also suggests that in the early phase of Wnt3a activation, stabilized beta-catenin originates from existing mRNA pools and is not translationally derived from newly transcribed mRNA.
###end p 12
###begin title 13
Dependence of Wnt3a-driven accumulation of cellular beta-catenin on new protein but not RNA synthesis.
###end title 13
###begin p 14
L-cells were treated with Wnt3a (50 ng/ml) in the absence or presence of either cycloheximide (CHX, 100 microg/ml) or actinomycin D (ActD, 1 microM) and incubated for the indicated times (n = 4).
###end p 14
###begin p 15
###xml 405 409 396 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003498-Lee2">[15]</xref>
###xml 556 565 541 550 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4A</bold>
###xml 556 565 541 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003498-g004"><bold>Figure 4A</bold></xref>
###xml 706 715 685 694 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4A</bold>
###xml 706 715 685 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003498-g004"><bold>Figure 4A</bold></xref>
###xml 919 921 895 897 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 1048 1060 1021 1033 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4B, C</bold>
###xml 1048 1060 1021 1033 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003498-g004"><bold>Figure 4B, C</bold></xref>
###xml 1082 1084 1055 1057 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 1193 1202 1142 1151 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4C</bold>
###xml 1193 1202 1142 1151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003498-g004"><bold>Figure 4C</bold></xref>
###xml 1484 1493 1430 1439 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4D</bold>
###xml 1484 1493 1430 1439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003498-g004"><bold>Figure 4D</bold></xref>
###xml 1784 1793 1715 1724 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4E</bold>
###xml 1784 1793 1715 1724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003498-g004"><bold>Figure 4E</bold></xref>
###xml 1832 1834 1763 1765 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 1923 1932 1854 1863 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4F</bold>
###xml 1923 1932 1854 1863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003498-g004"><bold>Figure 4F</bold></xref>
###xml 2132 2144 2048 2060 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4E, F</bold>
###xml 2132 2144 2048 2060 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003498-g004"><bold>Figure 4E, F</bold></xref>
###xml 2434 2438 2344 2348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003498-Lee2">[15]</xref>
Little is known about the experimental rate of accumulation of endogenous beta-catenin upon Wnt activation in mammalian cells. To develop a better quantitative understanding of the Wnt/beta-catenin pathway, I determined the initial rate of accumulation of cellular beta-catenin upon Wnt pathway activation and studied in detail its dependence on Wnt3a concentration in L-cells. A simplified kinetic model [15] of the Wnt/beta-catenin pathway depicts that under basal conditions beta-catenin is degraded due to a predominantly high rate of phosphorylation (Figure 4A). The presence of Wnt3a inhibits phosphorylation of beta-catenin, thus stabilizing beta-catenin and preventing its proteasomal degradation (Figure 4A). The model assumes that the intrinsic turnover rate of beta-catenin through mechanisms other than phosphorylation and that are independent of Wnt is minimal. First, the effective Wnt3a concentration (EC50) for half-maximal accumulation of intracellular beta-catenin was calculated and shown to depend on the period of stimulation (Figure 4B, C). For example, the EC50 is approximately30 ng/ml for 4 h-35 h and approximately50-70 ng/ml for only 1 h-2 h stimulation with Wnt3a (Figure 4C). These measurements define the sensitivity of the assay and establish optimal conditions for usage. Furthermore, beta-catenin levels are upregulated within 30 mins after Wnt3a stimulation, exhibit a noticeable increase in intensity between 6-8 h, and start to plateau after 10 h (Figure 4D). The rate of beta-catenin accumulation reflects its rate of cellular translation, which varies according to the concentration of Wnt3a presented to cells. At Wnt3a concentrations lower than approximately50 ng/ml, there is a linear correlation between initial rate and Wnt3a concentration (Figure 4E); for example, the rate is 0.002 FI. h-1 at 1.6 ng/ml Wnt3a and increases by 4-fold upon quadrupling the concentration of Wnt3a (Figure 4F). However, at Wnt3a concentrations higher than approximately50 ng/ml, this linear relationship is lost as intracellular beta-catenin starts to reach steady-state pools (see inflection and plateau in Figure 4E, F). In summary, the method reveals an unprecedented level of detail about the rate of accumulation of intracellular beta-catenin, and is useful for deriving quantitative kinetic parameters about the Wnt/beta-catenin pathway that may serve as basis for future kinetic modeling of the pathway [15]. Further investigation into the kinetic rate of beta-catenin degradation is beyond the scope of this paper.
###end p 15
###begin title 16
Kinetics of cellular beta-catenin accumulation upon stimulation with Wnt3a.
###end title 16
###begin p 17
###xml 145 146 139 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 146 147 140 141 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 152 153 146 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 153 154 147 148 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 522 523 510 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</italic>
###xml 523 524 511 512 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 682 683 667 668 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</italic>
###xml 683 684 668 669 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 899 901 881 883 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
(A) Kinetic model of cellular beta-catenin accumulation. The model assumes negligible beta-catenin turnover in the presence of Wnt3a activation. K1 and K2 denote the rate constants of beta-catenin translation and phosphorylation, respectively. (B) Time- and dose-dependent accumulation of cellular beta-catenin. L-cells were incubated with varying concentrations of Wnt3a for the indicated times. (C) Dose titration of Wnt3a at various time points. The curves are fitted to a non-linear variable slope sigmoidal equation (R2 values 0.990-0.999). (D) Kinetics of beta-catenin accumulation at different Wnt3a concentrations. The curves are fitted to a non-linear polynomial equation (R2 values 0.970-0.999). (E, F) Initial rates of cellular beta-catenin accumulation as a function of Wnt3a concentration. Rates were calculated from slopes of the fitted lines during the initial 2 h of treatment. FI. h-1 denotes fluorescence intensity per hour. All plots are representative of two independent experiments, each carried out in quadruplicate.
###end p 17
###begin p 18
###xml 1425 1429 1398 1402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003498-Rubinfeld2">[16]</xref>
In conclusion, probing Wnt signaling at the cellular level in a quantitative manner is essential to understanding the signaling cascades implicated in this pathway. The described multi-parametric method is a rapid way to quantify levels of endogenous beta-catenin and identify non-specific cytotoxic conditions that result in artifactual readouts. The assay is high-throughput and economical since it is conducted in a 384-well plate format and hence utilizes very small amounts of the expensive purified Wnt3a material. It also offers reproducibility and great speed compared to gel electrophoresis and western blotting. It can easily be used as a secondary screening assay to quickly assess whether pharmacologic inhibitors of Wnt/beta-catenin signaling act upstream or downstream of beta-catenin. For example, the Wnt inhibitor quercetin has no effect on Wnt-mediated beta-catenin accumulation, indicating that it acts downstream of beta-catenin. The limitation of the current method, however, is that it lacks spatial resolution and thus does not provide information on the cytoplasmic or nuclear localization of beta-catenin nor its translocation behavior. Nevertheless, this assay is a quick diagnostic readout for (1) screening and validating the mechanism of action of modulators of beta-catenin or GSK3beta, and (2) quantifying the basal and Wnt-induced expression levels of beta-catenin across different cell types [16]. In addition, this method offers temporal dynamic resolution and thus can be used to measure the kinetic rate of beta-catenin translation as well as turnover and stabilization.
###end p 18
###begin title 19
Materials and Methods
###end title 19
###begin title 20
Reagents
###end title 20
###begin p 21
###xml 189 190 183 184 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 539 543 521 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003498-Emami1">[14]</xref>
###xml 648 652 630 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003498-Willert1">[17]</xref>
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 136 142 <span type="species:ncbi:9913">bovine</span>
###xml 271 274 <span type="species:ncbi:9685">cat</span>
###xml 343 348 <span type="species:ncbi:10090">mouse</span>
###xml 586 591 <span type="species:ncbi:10090">Mouse</span>
###xml 613 618 <span type="species:ncbi:10090">mouse</span>
Mouse fibroblast L-cells were obtained from ATCC, maintained as per the manufacturer's recommendations in growth medium (DMEM/10% fetal bovine serum) in an incubator at 37degreesC and 5% CO2. Cell-Bindtrade mark 384-well plates and monoclonal anti-beta-catenin antibody [cat # 610154] were purchased from Becton-Dickinson (San Jose, CA). Anti-mouse IRDye800CW and DRAQ5 (far-red) were obtained from Rockland (Gilbertsville, PA). All chemicals were purchased from Sigma (St. Louis, MO). ICG-001, prepared according to literature precedence [14], was from Janet Gunzner (Genentech Inc.). Mouse Wnt3a, purified from mouse L-cells as described earlier [17], was obtained from James Ernst (Genentech Inc.).
###end p 21
###begin title 22
Cellular beta-catenin Assay
###end title 22
###begin p 23
###xml 145 146 135 136 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 288 297 275 284 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure S2</bold>
###xml 288 297 275 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003498.s002"><bold>Figure S2</bold></xref>
###xml 600 601 577 578 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1263 1268 <span type="species:ncbi:10090">mouse</span>
###xml 1506 1511 <span type="species:ncbi:10090">mouse</span>
On Day 1, L-cells (5000 cells/20 microl/well) were seeded in a clear bottomed, black walled 384-well plate and grown for 24 h at 37degreesC/5% CO2 (The method quantitatively detects beta-catenin levels in other cell lines such as SW480, HCT15 (colorectal cancer) and U2OS (osteosarcoma); Figure S2. Cell densities are as follows: SW480: 6000 cells/well, U2OS: 5000 cells/well, HCT15: 6000 cells/well). On Day 2, the cells were treated with 20 microl of a 2x stock of Wnt3a dissolved in growth medium at the indicated concentration and then incubated for the desired amount of time at 37degreesC/5% CO2. For treatment with various stimuli or inhibitors, 20 microl of 2x stock of chemicals dissolved in growth medium such that the DMSO concentration did not exceed 0.5% were added to the wells and then incubated for the desired amount of time. The cells were then fixed in 4% PFA by adding 20 microl of 12% PFA directly to the wells for 1 h at room temperature. The wells were washed three times with PBS (50 microl/well), permeabilized with PBS/0.1% Triton X-100 (50 microl/well, three times, 2 mins each), and blocked in LI-COR buffer (50 microl/well) for 2 hours at room temperature (or alternatively overnight at 4degreesC). The wells were then incubated with mouse anti-beta-catenin antibody (1: 200 for optimal signal-to-noise ratio) in LI-COR blocking buffer for 2 hours at room temperature (20 microl/well) and subsequently washed with PBS/0.1% Tween-20 (50 microl/well, three times). Infrared anti-mouse IRDye800CW secondary antibody (1: 200) and DRAQ5 (1: 10,000) in PBS/0.5% Tween-20 were then added (20 microl/well). The plates were incubated for 1 hour at room temperature, and the wells were washed with PBS/0.1% Tween-20 (three times) and incubated in PBS (50 microl/well). The plates were covered with black seals and imaged on an Odyssey infrared scanner using microplate2 settings with sensitivity of 5 in both the 700 and 800 nm wavelength channels. Data were acquired by using Odyssey software, exported and analyzed in Excel (Microsoft, Redmond, WA) or KaleidaGraph (Synergy Software). beta-catenin values were background subtracted from wells treated only with secondary antibody, and then normalized to cell numbers by dividing by the total DNA fluorescence signal.
###end p 23
###begin title 24
Supporting Information
###end title 24
###begin p 25
Monitoring cellular beta-catenin accumulation in response to the Wnt/beta-catenin pathway inhibitor ICG-001. L-cells were treated with Wnt3a (50 ng/ml) in the absence or presence of 10 microM ICG-001 for the indicated times. Each point represents mean+/-SEM (n = 4).
###end p 25
###begin p 26
(0.27 MB TIF)
###end p 26
###begin p 27
Click here for additional data file.
###end p 27
###begin p 28
###xml 297 302 <span type="species:ncbi:10090">mouse</span>
Detection of cellular beta-catenin in osteosarcoma U2OS cells, and SW480 and HCT15 colon cancer cell lines. (A) Titration of beta-catenin mAb. U2OS cells were incubated in the absence of presence of Wnt3a (50 ng/ml) for 24 h. (B) Detection of beta-catenin in SW480 and HCT15 cell lines. m denotes mouse species.
###end p 28
###begin p 29
(0.20 MB TIF)
###end p 29
###begin p 30
Click here for additional data file.
###end p 30
###begin p 31
###xml 91 96 <span type="species:ncbi:10090">mouse</span>
###xml 188 193 <span type="species:ncbi:28478">Tania</span>
I thank Dr. Paul Polakis for helpful discussions, Dr. James Ernst for the generous gift of mouse Wnt3a and Dr. Janet Gunzner for synthesis of ICG-001. I also thank Drs. Andrea Cochran and Tania Gonzales for helpful comments on the manuscript.
###end p 31
###begin title 32
References
###end title 32
###begin article-title 33
Wnt signalling in development and disease. Max Delbruck Center for Molecular Medicine meeting on Wnt signaling in Development and Disease.
###end article-title 33
###begin article-title 34
The many ways of Wnt in cancer.
###end article-title 34
###begin article-title 35
The Wnt signaling pathway in development and disease.
###end article-title 35
###begin article-title 36
Direct evidence for a role of beta-catenin/LEF-1 signaling pathway in induction of EMT.
###end article-title 36
###begin article-title 37
###xml 63 67 <span type="species:ncbi:10090">mice</span>
Real-time imaging of beta-catenin dynamics in cells and living mice.
###end article-title 37
###begin article-title 38
Axin prevents Wnt-3a-induced accumulation of b-catenin.
###end article-title 38
###begin article-title 39
A novel cell permeant and far red-fluorescing DNA probe, DRAQ5trade mark, for blood cell discrimination by flow cytometry.
###end article-title 39
###begin article-title 40
Both ERK and Wnt/ss-catenin pathways are involved in Wnt3a-induced proliferation.
###end article-title 40
###begin article-title 41
Wnt signaling and cancer.
###end article-title 41
###begin article-title 42
Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly.
###end article-title 42
###begin article-title 43
A molecular mechanism for the effect of lithium on development.
###end article-title 43
###begin article-title 44
###xml 97 121 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Selective inhibitors of the proteasome-dependent and vacuolar pathways of protein degradation in Saccharomyces cerevisiae.
###end article-title 44
###begin article-title 45
Quercetin, a potent inhibitor against beta-catenin/Tcf signaling in SW480 colon cancer cells.
###end article-title 45
###begin article-title 46
A small molecule inhibitor of beta-catenin/CREB-binding protein transcription.
###end article-title 46
###begin article-title 47
The roles of APC and Axin derived from experimental and theoretical analysis of the Wnt pathway.
###end article-title 47
###begin article-title 48
Stabilization of beta-catenin by genetic defects in melanoma cell lines.
###end article-title 48
###begin article-title 49
Wnt proteins are lipid-modified and can act as stem cell growth factors.
###end article-title 49
###begin p 50
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The author has declared that no competing interests exist.
###end p 50
###begin p 51
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was funded by Genentech, Inc.
###end p 51

